摘要 |
This invention is related to compounds and use of N-Acyl-N'-benzyl-alkylendiamino derivatives of the following general formula (I), wherein A is a straight or branched C<SUB>2</SUB>-C<SUB>8 </SUB>alkyl chain; X is a methylene, oxygen, sulphur or a NR<SUP>7 </SUP>group; R<SUP>1 </SUP>is a straight or branched C<SUB>1</SUB>-C<SUB>8 </SUB>alkyl or C<SUB>3</SUB>-C<SUB>8 </SUB>alkenylene or C<SUB>3</SUB>-C<SUB>8 </SUB>alkynylene chain, optionally substituted with CF<SUB>3</SUB>, phenyl, phenoxy or naphthyl, the aromatic rings optionally substituted by one or more C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, halogens, trifluoromethyl, hydroxy or C<SUB>1</SUB>-C<SUB>4 </SUB>alkoxy groups; R<SUP>2</SUP>, R<SUP>3 </SUP>are independently hydrogen, a C<SUB>1</SUB>-C<SUB>3 </SUB>alkyl chain, halogen, trifluoromethyl, hydroxy or C<SUB>1</SUB>-C<SUB>4 </SUB>alkoxy groups; R<SUP>4</SUP>, R<SUP>5 </SUP>are independently hydrogen or C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl; R<SUP>6 </SUP>is a hydrogen or a straight or branched C<SUB>1</SUB>-C<SUB>8 </SUB>alkyl or linked to R<SUP>5 </SUP>can form a five to seven membered lactam; R<SUP>7 </SUP>is hydrogen or C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl; and the pharmaceutically acceptable salts thereof that are active as sodium and/or calcium channel modulators and therefore useful in preventing, alleviating and curing a wide range of pathologies, including, but not limited to, neurological, psychiatric, cardiovascular, inflammatory, ophthalmic, urologic, metabolic and gastrointestinal diseases, where the above mechanisms have been described as playing a pathological role
|